HCWB (HCW Biologics, Inc.) Bozor qiymatining balans qiymatiga nisbati
HCW Biologics Inc. (HCWB) pul oqimlari saraton bilan kurashish uchun selektiv immun aktivatsiyaga tayanadi. Kompaniyaning GURU.Markets interfeysidagi joriy P/B koeffitsiyenti ushbu grafikda aks ettirilgan bo'lib, unda 0.25 ushbu metrikaning so'nggi qiymatini ifodalaydi. Startap hozirda kapitalni jalb qilish uchun birlamchi tadqiqotlarni nashr etmoqda va global ishtirokchilarga litsenziyalash orqali innovatsion platformalarni monetizatsiya qilish imkonini beruvchi kengaytiriladigan patent portfelini shakllantirmoqda.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_HCWB_-_HCW-Biologics-Inc._-_Market-Capitalization-to-Net-Assets "HCWB HCW Biologics Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
HCW Biologics Inc. (HCWB) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati HCW Biologics Inc.|HCWB - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati hcwbiologics.com|HCWB - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar HCW Biologics Inc|HCWB - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari HCW Biologics
Kompaniyaning dastlabki tahlili:HCW Biologics, Inc. - HCWB
HCW Biologics Inc. (HCWB) onkologiya va yoshga bog'liq o'zgarishlarga qarshi kurashish uchun innovatsion usullarni ishlab chiqishga e'tibor qaratadi. Ushbu ko'rsatkich investor emitentning sof aktivlarining har bir dollari uchun to'laydigan bozor premiyasi hajmini belgilaydi. Yuqori qiymatlar ko'pincha TOIB platformasi va HCW9218 dasturining muvaffaqiyatiga oid bozor kutganlarini aks ettiradi. Haddan tashqari past raqamlar aktivlarning qadrsizlanganini yoki yashirin biznes risklarini ko'rsatishi mumkin. Kompaniyaning bozor qiymatining buxgalteriya qiymatiga nisbati bo'yicha narxlar dinamikasi spekulyativ talabning joriy darajasini aniq ko'rsatadi.
Asosiy raqobatchilar
argenx SE (ARGX) - Bozor kapitallashuvining balans qiymatiga nisbati|BNTX (biontech.de) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|Bozor kapitallashuvining balans qiymatiga nisbati Rigel Pharmaceuticals Inc (RIGL)|ANAB - Balans qiymatiga nisbatan bozor qiymati|ATXS (Astria Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati engene.com|Kapitallashuvning sof aktivlarga nisbati RAPT|Kapitallashuvning sof aktivlarga nisbati Aerovate (JBIO)|Aclaris (ACRS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Kyverna Therapeutics, Inc (KYTX)|Bozor kapitallashuvining balans qiymatiga nisbati Tiziana Life Sciences TLSA|Bozor qiymatining balans qiymatiga nisbati cabalettabio.com CABA|Bozor kapitallashuvining balans qiymatiga nisbati VTYX (Ventyx Biosciences, Inc.)|THTX: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati AVTX|ELDN (Eledon Pharmaceuticals, Inc) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Agenus|Bozor qiymatining balans qiymatiga nisbati CLYM|Zura Bio - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti aTyr Pharma Inc (ATYR)|ADAG (Adagene Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati ImageneBio IMA|Bozor kapitallashuvining balans qiymatiga nisbati STTK (Shattuck Therapeutics)|EQ - Balans qiymatiga nisbatan bozor kapitallashuvi|CNTB (connectbiopharm.com) - Bozor kapitallashuvining balans qiymatiga nisbati|IMUX (Immunic) - Kapitallashuvning sof aktivlarga nisbati|ATRA: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi InflaRx GmbH (IFRX)|X4 Pharmaceuticals (XFOR) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati adicetbio.com (ACET)|Bozor kapitallashuvining balans qiymatiga nisbati CELU|INmune Bio Inc - Balans qiymatiga nisbatan bozor kapitallashuvi|Barinthus Bio (BRNS) - Bozor qiymatining balans qiymatiga nisbati|KZR - Kapitallashuvning balans qiymatiga nisbati|SABS (SAB Biotherapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati akaritx.com|ENLV: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Q32 Bio Corp|GeoVax Labs Inc (GOVX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Edesa Biotech Corp (EDSA)|iBio, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|CARM - Kapitallashuvning sof aktivlarga nisbati|XTLB: Kapitallashuvning sof aktivlarga nisbati|BOLT - Kapitallashuvning sof aktivlarga nisbati|aptevotherapeutics.com (APVO) - Bozor kapitallashuvining balans qiymatiga nisbati|AIM (aimimmuno.com) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc. ADTX|Sof aktivlarga nisbatan bozor kapitallashuvi gribio.com|XORTX Therapeutics (XRTX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Vyome Holdings Inc. (HIND)|Bozor kapitallashuvining balans qiymatiga nisbati REVB (Revelation Bio)|Indaptus Corp - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Scinai Immunotherapeutics (SCNI)|CALI: Balans qiymatiga nisbatan bozor qiymati|AFMD (affimed.com) - Bozor qiymatining balans qiymatiga nisbati|Allakos (ALLK) - Kapitallashuvning sof aktivlarga nisbati|HOOK (HOOKIPA Pharma, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IGM Bio (IGMS)|iTeos Therapeutics (ITOS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TCBP|Third Harmonic Bio Inc. - Balans qiymatiga nisbatan bozor kapitallashuvi